drugset / Trial / NCT00918554

Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis

NCT00918554

Phase 4 Terminated 7 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether methotrexate is a effective corticosteroid sparing agent in the treatment of sarcoid-associated uveitis.

Timeline

Start
2009-09
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 0.3 mg/kg Oral